Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-018077
Filing Date
2008-03-13
Accepted
2008-03-13 20:59:07
Documents
1
Period of Report
2008-03-11

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c72703b_tg4.html 4  
1 MAIN DOCUMENT DESCRIPTION c72703b_tg4.xml 4 3791
  Complete submission text file 0001209191-08-018077.txt   5916
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Issuer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 102 PICKERING WAY EXTON PA 19341
Business Address 484-875-3099
Greenspan Todd James (Reporting) CIK: 0001325011 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31564 | Film No.: 08687558